SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-19-127354
Filing Date
2019-04-30
Accepted
2019-04-30 08:02:05
Documents
7
Effectiveness Date
2019-04-30

Document Format Files

Seq Description Document Type Size
1 DEFA14A d634641ddefa14a.htm DEFA14A 34954
2 GRAPHIC g634641g05e15.jpg GRAPHIC 23408
3 GRAPHIC g634641g16q56.jpg GRAPHIC 13701
4 GRAPHIC g634641g22d56.jpg GRAPHIC 25156
5 GRAPHIC g634641g62d05.jpg GRAPHIC 24728
6 GRAPHIC g634641g76c99.jpg GRAPHIC 32714
7 GRAPHIC g634641g87n84.jpg GRAPHIC 13084
  Complete submission text file 0001193125-19-127354.txt   219491
Mailing Address 6400 WESTWIND WAY SUITE A CRESTWOOD KY 40014
Business Address 6400 WESTWIND WAY SUITE A CRESTWOOD KY 40014 502-241-4114
Apellis Pharmaceuticals, Inc. (Filer) CIK: 0001492422 (see all company filings)

IRS No.: 271537290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38276 | Film No.: 19778548
SIC: 2834 Pharmaceutical Preparations